Qed Therapeutics
Qed Therapeutics is a small Molecule Targeting Tyrosine Kinase Receptors founded in 2018.
Industries
Qed Therapeutics is active in the following industries:
- Consumer biotechnology
- Biomedical engineering
- Biopharmaceutical
- Healthcare
- Pharmaceutical industry
- Engineering
- Technology
- Biology
- Biotechnology